Target intelligence / Profile preview

NLRP3–NEK7 complex (NLRP3–NEK7)

Target
NLRP3–NEK7
Molecular classification
Other (protein–protein complex), Enzyme (NEK7 is a serine/threonine kinase), Receptor (NLRP3 is a pattern recognition receptor/NOD-like receptor family member)
01

Overview

The NLRP3–NEK7 complex is a critical protein–protein interaction that licenses the activation of the NLRP3 inflammasome, a multiprotein platform responsible for sensing cellular damage and triggering inflammatory responses through the maturation and secretion of pro-inflammatory cytokines, such as interleukin-1β and interleukin-18. NLRP3 serves as a cytosolic pattern recognition receptor, while NEK7, a serine/threonine kinase, interacts with and facilitates the oligomerization and activation of NLRP3 under conditions of cellular stress, such as potassium efflux or damage-associated signals. Disruption of the NLRP3–NEK7 interaction is a validated strategy for attenuating inflammasome-driven pathologies, including auto-inflammatory and neurodegenerative diseases, though targeting this axis must balance efficacy with potential adverse effects on cell division and immune function.

Other names
NLRP3–NEK7 interactionNLRP3–NEK7 interfaceNLRP3–NEK7 inflammasome complex
02

Mechanism of action

Inhibition of NLRP3–NEK7 binding to suppress inflammasome assembly/activation Blockade of ATP binding to NLRP3 NACHT domain Allosteric modulation of NLRP3 conformation to prevent NEK7 engagement

03

Biological functions

Inflammasome assemblyInnate immune responsePyroptosisRegulation of inflammation
04

Disease associations

InflammationAutoimmune diseaseNeurodegenerative diseaseCardiovascular diseaseCancer (emerging evidence for roles in tumor microenvironment)Infection
05

Safety considerations

Potential for immunosuppression and increased infection riskOff-target effects on essential cell division pathways (NEK7 is also critical for mitosis)Possible impairment of host defense mechanisms against pathogens
06

Interacting drugs

MCC950

3 more in the full profile.

07

Biomarkers

IL-1βIL-18Caspase-1 activity

Beyond the preview

Go deeper on NLRP3–NEK7 complex (NLRP3–NEK7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NLRP3–NEK7 complex (NLRP3–NEK7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call